Evidence map›Paper›PMID 33228174›Full record

Trial reportInternational journal of environmental research and public health2020

Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.

Louisa G Gordon, Elizabeth G Eakin, Rosalind R Spence, Christopher Pyke, John Bashford, Christobel Saunders, Sandra C Hayes

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Louisa G GordonPopulation Health Department, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Royal Brisbane Hospital, Brisbane, Qld 4029, Australia.ORCID 0000-0002-3159-4249
Elizabeth G EakinFaculty of Medicine, School of Public Health, The University of Queensland, Herston, Brisbane, Qld 4006, Australia.
Rosalind R SpenceMenzies Health Institute Qld, Griffith University, Nathan, Brisbane, Qld 4111, Australia.
Christopher PykeMater Public and Private Hospital, South Brisbane, Qld 4101, Australia.
John BashfordThe Wesley Hospital, Auchenflower, Brisbane, Qld 4066, Australia.
Christobel SaundersFaculty of Health and Medical Sciences, University of Western Australia, Perth, WA 6009, Australia.
Sandra C HayesMenzies Health Institute Qld, Griffith University, Nathan, Brisbane, Qld 4111, Australia.
Griffith University · AUMater Private Hospital · AUQueensland University of Technology · AUThe University of Queensland · AUThe University of Western Australia · AUWesley Hospital · AU

Funding

National Breast Cancer Foundation n/a
6 · The paper itself

Abstract

Studies show conflicting results on whether exercise interventions to improve outcomes for women with breast cancer are cost-effective. We modelled the long-term cost-effectiveness of the

Indexed as

Breast NeoplasmsCost-Benefit AnalysisExercise TherapyFemaleFollow-Up StudiesHumansMarkov ChainsNeoplasm Recurrence, LocalQuality-Adjusted Life YearsQuality of Lifebreast cancercost-effectiveness analysiscost-utility analysisexercise

Identifiers

PMID33228174
PMCPMC7699530
OpenAlexW3109511009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.